BIOAF Projected Dividend Yield
biOasis Technologies Inc ( OTCBB : BIOAF )biOasis Technologies is an early stage biopharmaceutical company. Co. is engaged in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. Co.'s xB3 program describes its proprietary carrier, p97, and components thereof, to deliver therapeutics across the blood-brain barrier ("BBB"). 20 YEAR PERFORMANCE RESULTS |
BIOAF Dividend History Detail BIOAF Dividend News BIOAF Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |